Bexxar (tositumomab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bexxar (tositumomab), covering 2014-08-06 to 2014-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]